期刊文献+

罗布麻双层漂浮型脉冲释药片的制备 被引量:2

Preparation of bilayer floating gogbane tablets for pulsatile release
下载PDF
导出
摘要 目的制备用于节律性高血压治疗的罗布麻提取物漂浮型脉冲释药片。方法以崩解时间和溶出度为指标,筛选罗布麻提取物速释片芯的崩解剂,用混料设计优选最佳漂浮层处方,体外释药试验考察对时滞的影响。结果优选的处方和工艺条件为:交联聚维酮(PVPP)作为片芯崩解剂;包衣处方中羟丙甲基纤维素(HPMC K4M)作为凝胶材料,乳糖用量为20%;漂浮层以30%卡波姆(carbopol)、36.3%羟丙甲基纤维素、33.7%碳酸氢钠组合最优。体外释放试验表明,罗布麻双层漂浮型脉冲片在经6 h滞期后药物脉冲释放。结论罗布麻双层漂浮型脉冲片达到瞬间起漂并持续到预定的时滞期脉冲释药,满足节律性疾病的治疗要求。 AIM To develop a floating godbane leaf( Apocynum venetum L.) extract tablets with pulsatile drug delivery system for circadian rhythmic hypertension treatment. METHODS The disintegration time and dissolution rate were taken as indexes for selection of the disintegrating agent for a quick release tablet core and the mixing design to screen the optimal formula for the bilayer. The in vitro test was applied to evaluating the lag time of tablet release. RESULTS The optimum prescription and process conditions were made up by PVPP as the disintegrate agent for core materiel,HPMC K4 M with 20% lactose for gel material,30% carbopol,36. 3% HPMC K4 M,and 33. 7% sodium bicarbonate were employed for the pulsatile layer. In vitro release test showed that the release from bilayer floating pulsatile gogbane tablets began after six-hour time lag. CONCLUSION The bilayer floating godbane tablets for pulsatile release reach the target for instant floating and start the release at the expected time after the designed lag,and this qualifies the treatment of rhythmic diseases.
出处 《中成药》 CAS CSCD 北大核心 2015年第4期752-757,共6页 Chinese Traditional Patent Medicine
基金 四川省教育厅项目(12ZA042)
关键词 罗布麻 漂浮型脉冲释药系统 片剂 交联聚维酮(PVPP) 羟丙甲基纤维素(HPMC K4M) 卡波姆(carbopol) 制备 godbane leaf(Apocynum venetum) floating pulsatile drug delivery system tablets PVPP HPMC K4M carbopol preparation
  • 相关文献

参考文献17

  • 1Patel J,Dalvadi H,Shah D.Time and/or site specific drug delivery of floating pulsatile release delivery system[J].Sys Reviews Pharm,2011,2(1):59-65.
  • 2Saitoh T,Watanabe Y,Kubo Y,et al.Intragastric acidity and circadian rhythm[J].Biomed Pharmacother,2001,55(1):138s-141s.
  • 3Moore J G,Englert E.Circadian rhythm of gastric acid secretion in man[J].Nature,1970,226(5252):1261-1262.
  • 4Maharastra.Pulsatile drug delivery:current scenario[J].Int J Pharma Bio Sci,2011,2(3):332-343.
  • 5Pickering T G,James G D.Determinants and consequences of the diurnal rhythm of blood pressure[J].Am J Hypertens,1993,6(6):166S-169S.
  • 6Massin M M,Maeyns K,Withofs N,et al.Circadian rhythm of heart rate and heart rate variability[J].Arch Dis Child,2000,83(2):179-182.
  • 7Bodmeier R,Krogel I.Floating or pulsatile drug delivery systems based on coated effervescent cores[J].Int J Pharm,1999,187(2):175-184.
  • 8张瑜,武亚玲,耿燕娜,彭兴娟.盐酸青藤碱胃滞留型择时释药片的研制[J].中国中药杂志,2009,34(5):554-559. 被引量:6
  • 9邹豪,蒋雪涛.口服脉冲和定时释药系统[J].国外医学(药学分册),1999,26(1):33-36. 被引量:22
  • 10刘璧玉,陈燕忠,吕竹芬,叶星辰.脉冲释药技术在中药制剂中的应用[J].中国药师,2011,14(12):1816-1817. 被引量:4

二级参考文献32

  • 1邹豪,卢文芸,陈宙艳,高申,蒋雪涛.漂浮型脉冲释放胶囊的设计和研制[J].中国医药工业杂志,2004,35(10):595-599. 被引量:6
  • 2王鹏,王玉珠,沈建民.均匀设计及其在药学中的应用[J].沈阳药学院学报,1989,6(4):297-305. 被引量:74
  • 3王剑红,陆彬,胥佩菱,包定元,张自然.肺靶向米托蒽醌明胶微球的研究[J].药学学报,1995,30(7):549-555. 被引量:25
  • 4孔庆峰,李军.青藤碱研究新进展[J].中国中药杂志,2005,30(20):1573-1576. 被引量:43
  • 5宋洪涛,张倩,姜鹏,郭涛,陈大为,何仲贵.采用定时释药技术制备复方中药舒胸缓释制剂的研究[J].中国中药杂志,2006,31(17):1413-1417. 被引量:9
  • 6Anon. Scherer DDS develops" alarm clock" dose formulation [ J ]. Pharm J, 1991,247 ( 6646 ) : 138.
  • 7Kashyap N, Viswanad B, Sharma G, et al. Design and evaluation of bi- odegradable, biosensitive in situ gelling system for pulsatile delivery of insulin [ J ]. Biomaterials,2007,28 ( 11 ) :2051-2060.
  • 8Ravaine V,Ancla C, Catargi B. Chemically controlled closed-loop in- sulin delivery[ J]. J Controlled Release ,2008,132( 1 ) :2-11.
  • 9李元波,薛立安,殷建华,等.复方丹参脉冲片的制备工艺及体外释药特性研究[C].长春:中华中医药学会第九届制剂学术研讨会论文汇编,2008.129-135.
  • 10赵秀丽,吕昭云,胡海洋,等.雷公藤提取物口服脉冲凝胶微球的研究[c].北京:中国药学会第九届全国青年药学工作者最新科研成果交流会论文集,2008.402-407.

共引文献356

同被引文献20

  • 1何绍雄 宋开源 薛振南.时间药理学与时间治疗学[M].天津:天津科学技术出版社,1998.227-251.
  • 2Patel JK, Dalvadi HP, Shah DP. Time and/or site specific drug deli - very of floating pulsatile release delivery system [J]. Sys Rev Pharm,2011,2 (1) : 59 - 65.
  • 3Massin MM, Maeyns K, Withofs N, et al. Circadian rhythm of heart rate and heart rate variablity[J]. Arch Dis Child, 2000, 83 (2): 179 - 182.
  • 4Efentakis M, Koligliati S, Vlachou M. Design and evaluation of a dry coated drug delivery system with an impermeable cup, swellable top layer and pulsatile release [J]. Int J Pharm, 2006, 311(1 -2): 147 - 156.
  • 5Zou H, Jiang XT, Kong LS, et al. Design and evaluation of a dry coated drug delivery system with floating- pulsatile release [J ]. J Pharm Sci, 2008,97 ( 1 ) : 263 - 273.
  • 6Jessy S, Vishal P. Novel floating pulsatile approach for chrono- therapeutic release of indomethacin [J] . Dhaka Univ J Pharm Sci,2007,6(1): 37 -41.
  • 7Fukui M, Goda A, Komamura K, et al. Changes in collagen meta- bolism account for ventrieular functional recovery following beta- blocker therapy in patients with chronic heart failure [ J]. Heart Vessls,2016,31 (2) : 173 - 182.
  • 8马安翠,杨建琴.时辰药理学与临床用药[J].大理学院学报(综合版),2008,7(6):3-5. 被引量:3
  • 9张玫.不同服药时间对心绞痛患者预后的影响[J].华北煤炭医学院学报,2009,11(4):511-512. 被引量:6
  • 10申磊,白靖,曹德英,刘国磊.酒石酸美托洛尔双脉冲片的研制[J].中国药房,2012,23(9):825-828. 被引量:3

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部